Latest Stock Split Details
Key information about Larimar Therapeutics, Inc.'s most recent stock split
Split Date: 2020-05-29
Split Ratio: 1:12
Price Before Split: $1.03
Price After Split: $0.09
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 12.00 times fewer shares (a 1:12 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of Larimar Therapeutics, Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2020-05-29 | 1:12 | Yes | $1.03 | $0.09 |
About Larimar Therapeutics, Inc.
Company overview and industry information
Larimar Therapeutics, Inc. (LRMR) operates in the Biotechnology industry. The recent 1-for-12 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Biotechnology
Go to Larimar Therapeutics, Inc. Summary